A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas

Cell Reports

Volumn 21, Issue 3, 2017, Pages 784-797

  Ryan, Russell J H ^a,b,i   Petrovic, Jelena ^c   Rausch, Dylan M ^a,b   Zhou, Yeqiao ^c   Lareau, Caleb A ^a,b   Kluk, Michael J ^f   Christie, Amanda L ^e   Lee, Winston Y ^d   Tarjan, Daniel R ^a,b   Guo, Bingqian ^g   Donohue, Laura K H ^a,b   Gillespie, Shawn M ^a,b   Nardi, Valentina ^a   Hochberg, Ephraim P ^h   Blacklow, Stephen C ^g   Weinstock, David M ^e   Faryabi, Robert B ^c   Bernstein, Bradley E ^a,b   Aster, Jon C ^d   Pear, Warren S ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

ⁱ UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

chronic lymphocytic leukemia; lymphoma; mantle cell lymphoma; MYC; Notch signaling

Indexed keywords

B CELL SPECIFIC NOTCH REGULOME; B LYMPHOCYTE RECEPTOR; CELL PROTEIN; NOTCH RECEPTOR; UNCLASSIFIED DRUG; MYC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER CELL CULTURE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE BIOPSY; MANTLE CELL LYMPHOMA; MANTLE CELL LYMPHOMA CELL LINE; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BIOPSY; DRUG SCREENING; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE; METABOLISM; ONCOGENE; PATHOLOGY; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

ANIMALS; B-LYMPHOCYTES; BIOPSY; CELL DIFFERENTIATION; CELL LINE, TUMOR; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; LYMPH NODES; LYMPHOMA, B-CELL; MICE; ONCOGENES; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85032030412     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2017.09.066     Document Type: Article

References (53)

1. Ahmadiyeh, N., Pomerantz, M.M., Grisanzio, C., Herman, P., Jia, L., Almendro, V., He, H.H., Brown, M., Liu, X.S., Davis, M., et al. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc. Natl. Acad. Sci. USA 107 (2010), 9742–9746.
2. Aster, J.C., Pear, W.S., Blacklow, S.C., The varied roles of Notch in cancer. Annu. Rev. Pathol. 12 (2017), 245–275.
3. Beà, S., Valdés-Mas, R., Navarro, A., Salaverria, I., Martín-Garcia, D., Jares, P., Giné, E., Pinyol, M., Royo, C., Nadeu, F., et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc. Natl. Acad. Sci. USA 110 (2013), 18250–18255.
4. Brady, G., Whiteman, H.J., Spender, L.C., Farrell, P.J., Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation. J. Virol. 83 (2009), 6909–6916.
5. Bray, S.J., Notch signalling in context. Nat. Rev. Mol. Cell Biol. 17 (2016), 722–735.
6. Carotta, S., Willis, S.N., Hasbold, J., Inouye, M., Pang, S.H., Emslie, D., Light, A., Chopin, M., Shi, W., Wang, H., et al. The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation. J. Exp. Med. 211 (2014), 2169–2181.
7. Choe, J.Y., Yun, J.Y., Na, H.Y., Huh, J., Shin, S.J., Kim, H.J., Paik, J.H., Kim, Y.A., Nam, S.J., Jeon, Y.K., et al. MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma. Histopathology 68 (2016), 442–449.
8. Crowther-Swanepoel, D., Broderick, P., Di Bernardo, M.C., Dobbins, S.E., Torres, M., Mansouri, M., Ruiz-Ponte, C., Enjuanes, A., Rosenquist, R., Carracedo, A., et al. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat. Genet. 42 (2010), 132–136.
9. Edelmann, J., Holzmann, K., Miller, F., Winkler, D., Bühler, A., Zenz, T., Bullinger, L., Kühn, M.W., Gerhardinger, A., Bloehdorn, J., et al. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 120 (2012), 4783–4794.
10. Fabbri, G., Rasi, S., Rossi, D., Trifonov, V., Khiabanian, H., Ma, J., Grunn, A., Fangazio, M., Capello, D., Monti, S., et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J. Exp. Med. 208 (2011), 1389–1401.
11. Fabbri, G., Holmes, A.B., Viganotti, M., Scuoppo, C., Belver, L., Herranz, D., Yan, X.J., Kieso, Y., Rossi, D., Gaidano, G., et al. Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 114 (2017), E2911–E2919.
12. Gibson, S.E., Leeman-Neill, R.J., Jain, S., Piao, W., Cieply, K.M., Swerdlow, S.H., Proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene. Br. J. Haematol. 175 (2016), 173–175.
13. Gilbert, L.A., Horlbeck, M.A., Adamson, B., Villalta, J.E., Chen, Y., Whitehead, E.H., Guimaraes, C., Panning, B., Ploegh, H.L., Bassik, M.C., et al. Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell 159 (2014), 647–661.
14. Gonda, T.J., Ramsay, R.G., Adenoid cystic carcinoma can be driven by MYB or MYBL1 rearrangements: new insights into MYB and tumor biology. Cancer Discov. 6 (2016), 125–127.
15. Henkel, T., Ling, P.D., Hayward, S.D., Peterson, M.G., Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265 (1994), 92–95.
16. Herranz, D., Ambesi-Impiombato, A., Palomero, T., Schnell, S.A., Belver, L., Wendorff, A.A., Xu, L., Castillo-Martin, M., Llobet-Navás, D., Cordon-Cardo, C., et al. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat. Med. 20 (2014), 1130–1137.
17. Jitschin, R., Braun, M., Qorraj, M., Saul, D., Le Blanc, K., Zenz, T., Mougiakakos, D., Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling. Blood 125 (2015), 3432–3436.
18. Johansen, L.M., Deppmann, C.D., Erickson, K.D., Coffin, W.F. 3rd, Thornton, T.M., Humphrey, S.E., Martin, J.M., Taparowsky, E.J., EBNA2 and activated Notch induce expression of BATF. J. Virol. 77 (2003), 6029–6040.
19. Kiel, M.J., Velusamy, T., Betz, B.L., Zhao, L., Weigelin, H.G., Chiang, M.Y., Huebner-Chan, D.R., Bailey, N.G., Yang, D.T., Bhagat, G., et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J. Exp. Med. 209 (2012), 1553–1565.
20. Kim, U., Qin, X.F., Gong, S., Stevens, S., Luo, Y., Nussenzweig, M., Roeder, R.G., The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature 383 (1996), 542–547.
21. Kluk, M.J., Ashworth, T., Wang, H., Knoechel, B., Mason, E.F., Morgan, E.A., Dorfman, D., Pinkus, G., Weigert, O., Hornick, J.L., et al. Gauging NOTCH1 activation in cancer using immunohistochemistry. PLoS ONE, 8, 2013, e67306.
22. Kridel, R., Meissner, B., Rogic, S., Boyle, M., Telenius, A., Woolcock, B., Gunawardana, J., Jenkins, C., Cochrane, C., Ben-Neriah, S., et al. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood 119 (2012), 1963–1971.
23. Krysov, S., Dias, S., Paterson, A., Mockridge, C.I., Potter, K.N., Smith, K.A., Ashton-Key, M., Stevenson, F.K., Packham, G., Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells. Blood 119 (2012), 170–179.
24. Kuhnert, F., Kirshner, J.R., Thurston, G., Dll4-Notch signaling as a therapeutic target in tumor angiogenesis. Vasc. Cell, 3, 2011, 20.
25. Li, Y., Hu, S., Wang, S.A., Li, S., Huh, Y.O., Tang, Z., Medeiros, L.J., Tang, G., The clinical significance of 8q24/MYC rearrangement in chronic lymphocytic leukemia. Mod. Pathol. 29 (2016), 444–451.
26. Maier, S., Staffler, G., Hartmann, A., Höck, J., Henning, K., Grabusic, K., Mailhammer, R., Hoffmann, R., Wilmanns, M., Lang, R., et al. Cellular target genes of Epstein-Barr virus nuclear antigen 2. J. Virol. 80 (2006), 9761–9771.
27. Martinez, I., Dimaio, D., B-Myb, cancer, senescence, and microRNAs. Cancer Res. 71 (2011), 5370–5373.
28. Nam, Y., Sliz, P., Song, L., Aster, J.C., Blacklow, S.C., Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. Cell 124 (2006), 973–983.
29. Pinnell, N., Yan, R., Cho, H.J., Keeley, T., Murai, M.J., Liu, Y., Alarcon, A.S., Qin, J., Wang, Q., Kuick, R., et al. The PIAS-like coactivator Zmiz1 is a direct and selective cofactor of Notch1 in T cell development and leukemia. Immunity 43 (2015), 870–883.
30. Pozzo, F., Bittolo, T., Vendramini, E., Bomben, R., Bulian, P., Rossi, F.M., Zucchetto, A., Tissino, E., Degan, M., D'Arena, G., et al. NOTCH1 mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin-1 and ribosome associated components. Leukemia, 2017, 10.1038/leu.2017.90 Published online April 18, 2017.
31. Puente, X.S., Pinyol, M., Quesada, V., Conde, L., Ordóñez, G.R., Villamor, N., Escaramis, G., Jares, P., Beà, S., González-Díaz, M., et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475 (2011), 101–105.
32. Puente, X.S., Beà, S., Valdés-Mas, R., Villamor, N., Gutiérrez-Abril, J., Martín-Subero, J.I., Munar, M., Rubio-Pérez, C., Jares, P., Aymerich, M., et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526 (2015), 519–524.
33. Ramsay, R.G., Gonda, T.J., MYB function in normal and cancer cells. Nat. Rev. Cancer 8 (2008), 523–534.
34. Rao, S.S., Huntley, M.H., Durand, N.C., Stamenova, E.K., Bochkov, I.D., Robinson, J.T., Sanborn, A.L., Machol, I., Omer, A.D., Lander, E.S., Aiden, E.L., A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159 (2014), 1665–1680.
35. Rossi, D., Spina, V., Deambrogi, C., Rasi, S., Laurenti, L., Stamatopoulos, K., Arcaini, L., Lucioni, M., Rocque, G.B., Xu-Monette, Z.Y., et al. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood 117 (2011), 3391–3401.
36. Rossi, D., Rasi, S., Fabbri, G., Spina, V., Fangazio, M., Forconi, F., Marasca, R., Laurenti, L., Bruscaggin, A., Cerri, M., et al. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 119 (2012), 521–529.
37. Ryan, R.J., Drier, Y., Whitton, H., cotton, m.j., kaur, j., issner, r., gillespie, s., epstein, c.b., nardi, v., sohani, a.r., et al. detection of enhancer-associated rearrangements reveals mechanisms of oncogene dysregulation in B-cell lymphoma. Cancer Discov. 5 (2015), 1058–1071.
38. Shen, H., McElhinny, A.S., Cao, Y., Gao, P., Liu, J., Bronson, R., Griffin, J.D., Wu, L., The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis. Genes Dev. 20 (2006), 675–688.
39. Shi, J., Whyte, W.A., Zepeda-Mendoza, C.J., Milazzo, J.P., Shen, C., Roe, J.S., Minder, J.L., Mercan, F., Wang, E., Eckersley-Maslin, M.A., et al. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev. 27 (2013), 2648–2662.
40. Skalska, L., Stojnic, R., Li, J., Fischer, B., Cerda-Moya, G., Sakai, H., Tajbakhsh, S., Russell, S., Adryan, B., Bray, S.J., Chromatin signatures at Notch-regulated enhancers reveal large-scale changes in H3K56ac upon activation. EMBO J. 34 (2015), 1889–1904.
41. Spender, L.C., Cornish, G.H., Sullivan, A., Farrell, P.J., Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. J. Virol. 76 (2002), 4919–4927.
42. Stoeck, A., Lejnine, S., Truong, A., Pan, L., Wang, H., Zang, C., Yuan, J., Ware, C., MacLean, J., Garrett-Engele, P.W., et al. Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma. Cancer Discov. 4 (2014), 1154–1167.
43. Tang, Z., Luo, O.J., Li, X., Zheng, M., Zhu, J.J., Szalaj, P., Trzaskoma, P., Magalska, A., Wlodarczyk, J., Ruszczycki, B., et al. CTCF-mediated human 3D genome architecture reveals chromatin topology for transcription. Cell 163 (2015), 1611–1627.
44. Townsend, E.C., Murakami, M.A., Christodoulou, A., Christie, A.L., Köster, J., DeSouza, T.A., Morgan, E.A., Kallgren, S.P., Liu, H., Wu, S.C., et al. The public repository of xenografts enables discovery and randomized phase II-like trials in mice. Cancer Cell, 30, 2016, 183.
45. Usui, T., Wakatsuki, Y., Matsunaga, Y., Kaneko, S., Koseki, H., Kita, T., Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype. J. Immunol. 158 (1997), 3197–3204.
46. Wang, H., Zang, C., Taing, L., Arnett, K.L., Wong, Y.J., Pear, W.S., Blacklow, S.C., Liu, X.S., Aster, J.C., NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers. Proc. Natl. Acad. Sci. USA 111 (2014), 705–710.
47. Weng, A.P., Ferrando, A.A., Lee, W., Morris, J.P. 4th, Silverman, L.B., Sanchez-Irizarry, C., Blacklow, S.C., Look, A.T., Aster, J.C., Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306 (2004), 269–271.
48. Weng, A.P., Millholland, J.M., Yashiro-Ohtani, Y., Arcangeli, M.L., Lau, A., Wai, C., Del Bianco, C., Rodriguez, C.G., Sai, H., Tobias, J., et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev. 20 (2006), 2096–2109.
49. Wu, Y., Cain-Hom, C., Choy, L., Hagenbeek, T.J., de Leon, G.P., Chen, Y., Finkle, D., Venook, R., Wu, X., Ridgway, J., et al. Therapeutic antibody targeting of individual Notch receptors. Nature 464 (2010), 1052–1057.
50. Xu, H., Chaudhri, V.K., Wu, Z., Biliouris, K., Dienger-Stambaugh, K., Rochman, Y., Singh, H., Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8. Nat. Immunol. 16 (2015), 1274–1281.
51. Yashiro-Ohtani, Y., Wang, H., Zang, C., Arnett, K.L., Bailis, W., Ho, Y., Knoechel, B., Lanauze, C., Louis, L., Forsyth, K.S., et al. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia. Proc. Natl. Acad. Sci. USA 111 (2014), E4946–E4953.
52. Zhao, Y., Katzman, R.B., Delmolino, L.M., Bhat, I., Zhang, Y., Gurumurthy, C.B., Germaniuk-Kurowska, A., Reddi, H.V., Solomon, A., Zeng, M.S., et al. The notch regulator MAML1 interacts with p53 and functions as a coactivator. J. Biol. Chem. 282 (2007), 11969–11981.
53. Zhao, B., Zou, J., Wang, H., Johannsen, E., Peng, C.-W., Quackenbush, J., Mar, J.C., Morton, C.C., Freedman, M.L., Blacklow, S.C., et al. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc. Natl. Acad. Sci. USA 108 (2011), 14902–14907.